Investing Profile

Kyle Kurpinski(3)

VCInvestor
Partner, Tencent Healthcare Investment Team at Tencent
tenx.tcSeattle, Washington
Photo of Kyle Kurpinski, Partner at Tencent Holdings
Your Intro Paths to Kyle Kurpinski

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
Networks Kyle is a member of
Top-Patents Network
1035 CONNECTIONS
University of California, Berkeley Network
362 CONNECTIONS
University of California, Berkeley Network
362 CONNECTIONS
Sm4rt Predictive Systems Network
291 CONNECTIONS
University of Michigan Network
132 CONNECTIONS

Find Kyle Kurpinski on

Current Investing Position
Tencent Holdings Partner
Investment Range
$100K - $30.0M
Sweet Spot
$15.0M
Investments On Record
15

Kyle Kurpinski is on these Sector & Stage Rankings

Kyle Kurpinski's Investments On Record (13)

CompanyStageDateRound SizeTotal Raised
Metagenomi
Series BJan 2022$180M
$180M
Culture Biosciences
Series BOct 2021$80M
seedApr 2018
$80M
Co-investors: Zal Bilimoria (Refactor Capital), Michael Dempsey (Compound), Steven Lurie (Team Builder Ventures)
Lassogen
Seed RoundOct 2020$4.5M
$4.5M
Mantra Bio
Series AJul 2020$25M
$25M
Atomwise
Series AMar 2018$45M
$45M
Co-investors: Matt Ocko (DCVC (Data Collective)), Saman Farid (Baidu Ventures), Xinhong Lim (Vickers Venture Partners), Kiersten Stead (DCVC Bio)
Locus Biosciences
Series ANov 2017$19M
$19M
Karius
Series AAug 2017$59M
$59M
Guardant Health
Series EMay 2017$360M
Series DJan 2016$100M
$460M

most interested in

I'm most interested in companies building deep core technologies to solve complex challenges in human health and planetary resiliency. I'm particularly drawn towards data-driven companies, and I focus heavily on those innovating at the intersection of data science and life science. I'm intrigued by the possibilities of using robotics, automation, miniaturization, and new high-throughput techniques to rapidly generate novel and actionable insights for users.

not interested in

I generally do not invest companies that lack a clear and defensible core technology.

Kyle Kurpinski's Experience

Partner, Tencent Healthcare Investment Team Tencent2025 - Present
Board Observer Broken String Biosciences2023 - Present
Angel Investor Angel Investor2018 - Present
Executive Director, Master of Translational Medicine Program BerkeleyLawPresent
Graduate Student Researcher (PhD program) BerkeleyLawPresent
Angel Investor InvestorPresent
Angel Investor Top-PatentsPresent
Author Penguin Random HousePresent
Angel Investor Sm4rt Predictive SystemsPresent
Board Observer (acting) kariusPresent
Executive Director, Master of Translational Medicine Program Underrespresented Researchers of ColorPresent
Senior Product Development Engineer SquadhelpPresent
Graduate Student Researcher (PhD program) Molecular RealityPresent
Graduate Student Researcher (PhD program) Underrespresented Researchers of ColorPresent
Executive Director, Investments, Tencent Exploration Team Tencent2022 - 2025
Partner, Tencent Exploration Team Tencent2016 - 2022
Board Observer Locus Biosciences, Inc.2017 - 2020
Board Observer (acting) Karius, Inc.2018 - 2020
Senior Manager, Strategic Initiatives, Tencent Exploration Team Tencent2015 - 2016
Executive Director, Master of Translational Medicine Program University of California, Berkeley2011 - 2015
Senior Product Development Engineer NanoNerve, Inc.2008 - 2011
Author Random House2007 - 2010
Graduate Student Researcher (PhD program) UC Berkeley2003 - 2008
Research Assistant National Institutes of Health2002 - 2002

Kyle Kurpinski's Education

University of Michigan Bachelor of Science (BS) Chemical Engineering
University of Michigan Master of Science (MS) Biomedical Engineering
University of California, Berkeley Ph.D. Bioengineering
University of California, Berkeley PhD Bioengineering
University of Michigan BS Chemical Engineering